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WbdD is a bifunctional kinase/methyltransferase that is
responsible for regulation of lipopolysaccharide O antigen
polysaccharide chain length in Escherichia coli serotype O9a.
Solving the crystal structure of this protein proved to be a
challenge because the available crystals belonging to space
group I23 only diffracted to low resolution (>95% of the
crystals diffracted to resolution lower than 4 A˚ and most only
to 8 A˚) and were non-isomorphous, with changes in unit-cell
dimensions of greater than 10%. Data from a serendipitously
found single native crystal that diffracted to 3.0 A˚ resolution
were non-isomorphous with a lower (3.5 A˚) resolution
selenomethionine data set. Here, a strategy for improving
poor (3.5 A˚ resolution) initial phases by density modification
and cross-crystal averaging with an additional 4.2 A˚ resolution
data set to build a crude model of WbdD is desribed. Using
this crude model as a mask to cut out the 3.5 A˚ resolution
electron density yielded a successful molecular-replacement
solution of the 3.0 A˚ resolution data set. The resulting map
was used to build a complete model of WbdD. The hydration
status of individual crystals appears to underpin the variable
diffraction quality of WbdD crystals. After the initial structure
had been solved, methods to control the hydration status of
WbdD were developed and it was thus possible to routinely
obtain high-resolution diffraction (to better than 2.5 A˚
resolution). This novel and facile crystal-dehydration protocol
may be useful for similar challenging situations.
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1. Introduction
The last two decades have seen a steady improvement of the
infrastructure and techniques that are used to express, purify
and crystallize proteins. Similarly, the actual structure-solution
process has become increasingly streamlined (Winn et al.,
2011; Adams et al., 2002; Winter, 2010). Structures can literally
be solved by a single keystroke and the process is routine
in many cases (Oke et al., 2010). The remaining hurdle is
obtaining reproducible high-quality crystals. This represents
a particular problem for challenging targets such as protein
complexes, membrane proteins and post-translationally
modified eukaryotic proteins. Occasionally, however, even
proteins that are anticipated to be routine prove to be difficult
and their study can identify approaches for a priori challen-
ging cases.
WbdD is a soluble protein that controls the length of
some lipopolysaccharide O-antigen polysaccharides that
are synthesized in an ABC-transporter-dependent pathway
(Cuthbertson et al., 2010). WbdD from Escherichia coli O9a
contains two enzymatic domains: a methyltransferase (MTase)
domain and a kinase domain (Clarke et al., 2004). WbdD stops
polymerization of the chain by phosphorylating and then
methylating the phosphate on the terminal sugar (Clarke et al.,
2009, 2011). The C-terminus of WbdD contains an amphi-
pathic helix that locates WbdD at the cytoplasmic face of the
inner membrane, as well as several predicted coiled-coil motifs
(Fig. 1a; Clarke et al., 2004) in a region that interacts with the
sugar polymerase WbdA (Clarke et al., 2009), generating a
complex for regulating chain extension and termination.
This bifunctionality of WbdD is unusual, so it was selected
for study by X-ray crystallography. However, WbdD unex-
pectedly proved to be an exceptionally challenging case and
here we report in detail how we tailored the expression
construct, phased the structure experimentally at low resolu-
tion and finally improved the diffraction quality of our crystals
by developing a new higher-throughput dehydration protocol
for protein crystals.
2. Methods
2.1. Protein production
The nucleotide sequence encoding WbdD600 (residues
1–600 of WbdD; accession No. JX235676) was cloned into
pBAD24 as described previously (Clarke et al., 2009). The
same cloning strategy was used for the WbdD556 sequence.
Both constructs introduced a tobacco etch virus (TEV)
cleavable N-terminal His tag (MHHHHHHENLYFQG; only
the C-terminal glycine remains as the new N-terminus after
TEV cleavage, a one-residue extension of the sequence of the
target protein). An identical expression and purification
procedure was followed for both proteins. The plasmids were
transformed into Escherichia coli Rosetta cells. A single
colony was selected and grown overnight in Luria broth (LB)
medium containing 100 mg ml1 ampicillin. The overnight
culture was used to inoculate 5 l LB medium at a ratio of 1:100.
This culture was grown at 310 K with shaking at
200 rev min1. Once the culture reached an optical density
(600 nm) of 0.4, the incubation temperature was lowered to
301 K. At an OD600 of 1.0, protein expression was induced by
adding l-arabinose to a final concentration of 0.2% and the
culture was incubated at 301 K for 5 h. The cells were
harvested by centrifugation at 7000g for 30 min. Cell pellets
containing the target proteins were resuspended in lysis buffer
[20 mM bis-Tris, 250 mM NaCl, 10 mM imidazole, 5%(w/v)
glycerol pH 7.0 and one Complete protease-inhibitor cocktail
tablet (Roche Diagnostics) per 50 ml of extract] and the
mixture was stirred at 277 K for 30 min. After treatment with a
cell disrupter (207 MPa; Constant Cell Disruption Systems,
Daventry, England), the lysate was clarified by centrifugation
at 30 000g for 1 h at 277 K. The cell-free supernatant was
loaded onto a 5 ml Ni–NTA column (GE Healthcare). Prior to
loading, the resin was equilibrated in lysis buffer. The loaded
resin was washed with lysis buffer and the target protein was
eluted with lysis buffer containing 1M imidazole. For final
purification, the protein was passed over a Superdex 200 16/60
column (GE Healthcare) and eluted with 20 mM bis-Tris pH
7.0, 50 mM NaCl. Fractions with appropriate purity, as judged
by SDS–PAGE, were pooled and concentrated to 10–
20 mg ml1 for crystallization. Protein identity and integrity
were confirmed by mass spectrometry. The protein was flash-
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Figure 1
(a) The primary structure of WbdD. The domain borders were placed
according to the crystal structure of WbdD556. (b) SDS–PAGE of
WbdD600 samples from limited proteolysis reactions. Lane M contains
NuPAGE Mark12 protein marker (Invitrogen). The molar ratio of
protease:WbdD600 is indicated. (c) Initial WbdD556 crystals (see main
text for the crystallization conditions). The dark colour of the crystals
arises from the Izit stain (Hampton) that was used to confirm that the
crystals are protein. (d) Optimized WbdD556 crystal.
cooled in liquid N2 using thin-walled PCR tubes and stored at
193 K prior to further use.
2.2. Production of selenomethionine-labelled WbdD556
Selenomethionine-labelled WbdD556 was prepared using
glucose-free SeMet medium from Molecular Dimensions.
Glycerol was added at a concentration of 5% to provide a
carbon source. The cells from a 100 ml overnight culture were
harvested by centrifugation and resuspended in phosphate-
buffered saline (PBS). The main culture was inoculated and
grown for 1 h at 310 K before seleno-l-methionine (SeMet)
was added (50 mg ml1). When an OD600 of 0.5 was reached,
the temperature was lowered to 301 K and protein expression
was induced by adding 0.2% l-arabinose. The SeMet protein
was purified in the same way as the native protein (see above).
2.3. Crystallization
Initial crystallization trials for WbdD600 and WbdD556
were performed using a Honeybee 963 robot system
(Genomic Solutions) with both commercially available and
self-made (Oke et al., 2010) crystallization screens. For each of
the 96-well sitting-drop vapour-diffusion screens (MRC plates,
Swissci), 150 nl protein solution (15 mg ml1 in 20 mM bis-
Tris pH 7.0, 50 mM NaCl supplemented with 5 mM each of
ATP, SAM and MgCl2) was mixed with 150 nl precipitant and
equilibrated against a reservoir of 75 ml precipitant. The sealed
plates were then incubated at 293 K.
Initial WbdD crystals were obtained in a condition
containing 51% Tacsimate pH 8.0 from the commercial Index
screen (Hampton Research) and were further optimized by
several rounds of stochastic optimizations in a 96-well format.
The best results, as judged by crystal appearance, were
obtained with a mixture of 0.26M lithium sulfate, 0.1M Tris–
HCl pH 8.4, 1.12M ammonium sulfate. Crystals (>100 mm)
usually appeared after 1–3 d at 293 K. Prior to flash-cooling in
liquid nitrogen for data collection, the crystals were cryopro-
tected by transferring them into either a saturated ammonium
sulfate solution or mother liquor supplemented with either
30% mannose, 30% ethylene glycol or 30% glycerol.
2.4. Limited proteolysis
The proteases thermolysin, papain, trypsin and subtilisin
(Sigma) were mixed with WbdD600 (1 mg ml1) in a 1:10 or a
1:100 molar ratio of protease:WbdD600. The mixtures were
incubated on ice for 1 h and the reactions were stopped by
adding boiling SDS–PAGE loading buffer (NuPAGE LDS
sample buffer, Invitrogen). The samples were then analyzed
by SDS–PAGE.
3. Results
3.1. Finding a suitable crystallization construct by limited
proteolysis
WbdD is a 82 kDa protein with 708 amino-acid residues
and two functional domains. The N-terminus of the protein
contains a methyltransferase (MTase) domain (residues 1–
210) followed by a kinase domain (residues 211–459) and a
C-terminal coiled-coil domain (residues 460–708) (Fig. 1a).
The full-length protein is difficult to solubilize and purify, but
we found a construct comprising amino acids 1–600 of WbdD
(WbdD600) that is expressed in sufficient amounts for crys-
tallization experiments (>100 mg per litre of culture). We
submitted the WbdD600 sequence to the XtalPred server
(Slabinski et al., 2007) to assess the likelihood of crystallization
and the protein was classified as ‘very difficult’. This is mainly
owing to its relatively large size and the presence of multiple
coiled-coil domains and the amphipathic helix (Fig. 1a).
Nevertheless, the protein was purified using a combination
of Ni–NTA, ion-exchange and gel-filtration chromatography
(Fig. 1b, lane 2). Although more than 1000 crystallization
conditions were tested at protein concentrations ranging from
5 to 40 mg ml1, no crystals were observed. We subjected the
protein to limited proteolysis in order to identify protease-
resistant domains which might facilitate crystallization.
Digestion with the protease subtilisin resulted in two stable
cleavage products (Fig. 1b). Analysis by mass spectrometry
revealed that 50 amino acids were removed from the
C-terminus of the protein. We therefore designed, cloned and
expressed a new construct, WbdD556 (residues 1–556), that
was purified in the same way as WbdD600. Although this
construct was still classified as ‘very difficult’ by XtalPred,
it readily crystallized in a Tacsimate-based condition (51%
Tacsimate pH 8.0, 5 mM SAM/Mg2+/ATP after optimization)
based on the commercially available Index screen (condition
29; Hampton Research; Fig. 1c). Condition 2.4 of The JCSG+
Suite (Molecular Dimensions) led to identical WbdD556
crystals growing from a mixture of lithium sulfate and
ammonium sulfate (0.26M lithium sulfate, 0.1M Tris–HCl pH
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Table 1
Overview of WbdD556 crystals that had been tested and/or used for data
collection at the time when the structure was solved.
Resolution
(A˚)
No. of
crystals
Unit-cell
parameter (A˚)
Type of
crystal
7–8 >500 185 Native, SeMet
4–5 20 182 Native, SeMet
3.5–4 3 177 SeMet
3.0 1 167 Native
Figure 2
Strength h|F+  F|/[(F+)2  (F)2]1/2i of the anomalous signal versus
resolution for the 3.5 A˚ resolution data set (Table 2) as calculated using
SHELXC (Sheldrick, 2008). The red line at y = 0.8 indicates the threshold
for the presence of an anomalous signal (Zwart, 2005).
8.4, 1.12M ammonium sulfate, 5 mM SAM/Mg2+/ATP after
optimization). We found that these crystals could also be
obtained by in situ proteolysis (Dong et al., 2007; Wernimont
& Edwards, 2009) by crystallizing WbdD600 in the presence of
low concentrations (1:1000 molar ratio of protease:WbdD) of
subtilisin or trypsin.
3.2. WbdD crystals vary in diffraction quality
The initial optimization of the cubic (space group I23)
WbdD crystals was based on their optical appearance and
proved to be straightforward; large crystals (>200 mm) could
be grown (Fig. 1d). However, these crystals typically did not
diffract to a resolution better than 7–8 A˚ (crystal category D).
From over 500 tested crystals, only a dozen diffracted to 4–5 A˚
resolution (crystal category C) and only three crystals to
around 3.5 A˚ resolution (crystal category B). An SeMet
derivative gave similar results. During crystal screening, we
noticed that the first crystal retrieved from a drop frequently
diffracted significantly better than subsequently harvested
crystals. We found a single native crystal that diffracted to
better than 3.0 A˚ resolution (crystal category A), although
there was no obvious visual indication as to why and this could
not be reproduced. This crystal grew from the ammonium
sulfate-based condition, but was harvested more than six
months after the plate had been set up. During the intervening
time, approximately half of the volume of the reservoir solu-
tion had evaporated, leaving a much higher (2M) concen-
tration of ammonium sulfate. By comparing the unit-cell
parameters of the different crystal categories (A, B, C and D),
we found that the decrease in length of the cubic unit-cell axis
from 185 A˚ in crystal category D to 167 A˚ in crystal category
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Figure 3
(a) Stereo pair of an electron-density map (1.0) calculated with the starting experimental phases after density improvement withAUTOSOLVE (Zwart
et al., 2008). The manually placed three-helix bundle is shown as a yellow tube model; the threefold crystallographic axis is indicated by a red line. (b) The
white mesh represents the same map as shown in (a). The purple map was calculated from phases that were improved using PARROT. Manually placed
secondary-structure elements are represented by yellow tubes. (c) The purple mesh is the same as in (b). The green map was calculated after cross-crystal
averaging between the 3.5 A˚ resolution data set and the 4.2 A˚ resolution data set (Table 2) using DMMULTI (Winn et al., 2011). Manually placed
secondary-structure elements are represented by yellow tubes. The crystal structure (white tubes) of the SAM-dependent methyltransferase from
Pyrococcus horikoshiiOT3 (PDB entry 1wzn; RIKEN Structural Genomics/Proteomics Initiative, unpublished work) is superimposed onto the manually
placed secondary-structure elements. (d) The green mesh is the same as in (c). The individual domains of WbdD556 are indicated (white,
methyltransferase domain; red, kinase domain; yellow, three-helix bundle).
A generally correlated with resolution. We interpreted this as
an indication that dehydration of the WbdD556 crystals
improved diffraction quality (Table 1).
3.3. Solving the selenium substructure and determining the
correct hand
WbdD556 crystals were sensitive to radiation damage and
the highest resolution SeMet data set was processed to 3.5 A˚
with HKL-2000 (Otwinowski & Minor, 1997; Table 2). The
anomalous signal was found to extend to about 4.5 A˚ resolu-
tion using SHELXC (Sheldrick, 2008) and phenix.xtriage
(Zwart et al., 2008) (Fig. 2), and five of the expected seven
selenium sites were located by SHELXD (Sheldrick, 2008).
However, the phasing and density-improvement step in
SHELXE (Sheldrick, 2008) did not result in an interpretable
map or even clear solvent boundaries in either hand. We
repeated the initial phasing steps with phenix.hyss (Grosse-
Kunstleve & Adams, 2003; Zwart et al., 2008) and SOLVE/
RESOLVE (Terwilliger, 2003) from the PHENIX suite
(Adams et al., 2002), but obtained similar results. In the map
corresponding to the original hand we noted a long tubular
stretch of electron density wound around the crystallographic
threefold axis, suggesting a coiled coil (Fig. 3a). No similar
structure was visible in the other hand. We inserted a 20-
residue helix model using Coot and submitted the resulting
crystallographic helical trimer to the DALI and SSM servers
(Holm & Rosenstro¨m, 2010; Krissinel & Henrick, 2004). Both
algorithms identified structures with similar arrangements of
helices (e.g. PDB entries 1xkm, 2lfh and 3aha; Raimondo et al.,
2005; Northeast Structural Genomics Consortium, unpub-
lished work; Izumi et al., 2010), supporting the notion that the
geometric arrangement of helices was reasonable. On this
basis, we tentatively selected the hand.
3.4. Additional density improvement to build a crude model
The Parrot program (Winn et al., 2011; Cowtan, 2010)
improved the map quality (Fig. 3b). The most significant
difference was a better defined solvent
boundary, which made it possible to
identify the elongated shape of the
molecule (Fig. 3b). We also tentatively
assigned secondary-structure elements.
Our strategy at this point was to
improve the model to a point where it
would be possible to phase the 3.0 A˚
resolution native data set by molecular
replacement. However this failed, indi-
cating that the model was substantially
incorrect. Owing to variations of the
unit-cell length, we had a collection of
non-isomorphous crystals (Tables 1 and
2) and we decided to try cross-crystal
averaging with DMMULTI. We defined
a mask around our crude model and
cross-crystal averaged using the 3.0 A˚
resolution native data set, assuming that
the mask occupied the same position relative to the threefold
axis and allowing the matrix to refine. Unfortunately, the
resulting maps were not interpretable. Employing the same
procedure with a 4.2 A˚ resolution data set resulted in a much
improved electron-density map (Fig. 3c) and sufficient
secondary-structural elements were fitted to confidently
identify the MTase domain. This defined which part of the map
corresponded to which of the two domains of WbdD. A model
of Src kinase could be placed by hand into the remaining
density, although the quality of fit was poor (Fig. 3d).
3.5. Molecular replacement with electron density
We suspected that the large changes in the unit-cell para-
meters were accompanied by domain reorganization within
the crystal. We proceeded by using the separate domains for
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Table 2
Data-collection statistics for WbdD556.
The 3.0 A˚ resolution data set was processed so that all data with I/(I) > 1.0 were included. Values in
parentheses are for the highest resolution shell
3.0 A˚, native 3.5 A˚, SeMet 4.2 A˚, native
Space group I23 I23 I23
Unit-cell parameters (A˚, ) a = b = c = 167.2,
 =  =  = 90
a = b = c = 177.6,
 =  =  = 90
a = b = c = 180.0,
 =  =  = 90
Matthews coefficient (A˚3 Da1) 3.1 3.7 3.88
Solvent content (%) 61 67 69
Molecules per asymmetric unit 1 1 1
Resolution range (A˚) 30.0–2.80 (2.85–2.80) 55.0–3.52 (3.59–3.52) 63.6–4.22 (4.33–4.22)
Total observations 197495 81347 153562
Unique reflections 19185 11716 7119
Completeness (%) 99.5 (97.5) 95.6 (98.3) 100 (100)
Rmerge† (%) 10.3 (200) 8 (84) 20 (57.1)
Multiplicity 10.3 6.9 21.6
hI/(I)i 20.1 (1.1) 30.2 (2.2) 14.8 (6.0)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity for all observations i of reflection
hkl and hI(hkl)i is the weighted average intensity for all observations i of reflection hkl.
Figure 4
Electron-density map (blue, 2m|Fobs|  D|Fcalc|, 1.0; green,
m|Fobs|  D|Fcalc|, 3.0; red, m|Fobs|  D|Fcalc|, 3.0) calculated from
phases directly after the masked electron densities shown in Fig. 3(c)
were used as a model for molecular replacement in the 3.0 A˚ resolution
data set (Table 2). The WbdD model (yellow) and the SAM cofactor
(white) are shown as sticks.
molecular replacement into the native 3.0 A˚ resolution data
set and found a convincing solution for the MTase domain
using PHASER (McCoy et al., 2007; TFZ score 16.7, LLG
232), but no solution for the kinase domain was found.
Inspection of the maps calculated from the molecular-repla-
cement phases showed no additional difference electron
density. This indicated that either the kinase domain was
disordered in these crystals or our incorrect model biased the
phases. We repeated molecular replacement using the density
for each domain (rather than the structure) as the search
model in an attempt to avoid model bias as much as possible.
Once again, the MTase domain was confidently located by
PHASER (McCoy et al., 2007), but multiple borderline solu-
tions were obtained for the kinase domain with low Z-scores
of 6 and LLGs of around 40. Inspection of the Euler angles
and translational shifts of the solutions revealed that the top
solution of this set was in close proximity to the MTase domain
solution. Phases calculated from the combined top solutions
then resulted in electron density that was interpretable for
both domains (Fig. 4). We were able to confidently build a
complete medium-resolution model of WbdD and refine
it by simulated annealing (R = 21.2%, Rfree = 23.3%; Fig. 5,
Table 3).
3.6. A new rapid dehydration method
Only after the preceding approaches resulted in a solved
medium-resolution structure of WbdD were we able to
develop a protocol that would give reproducible high-quality
crystals for further study.
To investigate the role of crystal dehydration in determining
data quality, we mounted crystals in a free-mounting system
(FMS; Proteros; Kiefersauer et al., 2000) and lowered the
relative humidity (r.h.) of the gas phase surrounding the
crystal. During this process, diffraction snapshots were taken
and these revealed a clear improvement in the diffraction
quality when the r.h. was lowered to 86% (Fig. 6). Indexing
of the individual diffraction images revealed that in the initial
stage (90% r.h.) the unit-cell parameter decreased (from 174
to 168 A˚) and the diffraction quality improved (Fig. 6).
Further dehydration (86% r.h.) led to only a slightly
decreased unit-cell size but significantly improved the
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Table 3
Refinement statistics for WbdD556.
The structure has been deposited in the PDB as entry 4ax8.
3.0 A˚, native
R (%) 21.2
Rfree (%) 23.3
R.m.s.d. bonds (A˚) 0.017
R.m.s.d. angles () 1.835
Ramachandran plot (%)
Allowed 97.3
Disallowed 0.2
MolProbity† score 1.86
MolProbity† clashscore 7.01
† Chen et al. (2010).
Figure 5
Cartoon model of the overall structure of a WbdD trimer. One monomer
is coloured green and the other two are shown in grey. The relative
positions of the MTase and kinase domains are indicated.
Figure 6
Right to left: dehydration of a WbdD556 crystal using a free-mounting system (Kiefersauer et al., 2000). As indicated, the diffraction images were taken
at different relative humidities (r.h.). The images were indexed with HKL-2000 (Otwinowski & Minor, 1997) to analyze the change in the cubic unit-cell
parameter.
diffraction quality. The change in unit-cell parameters renders
the crystals non-isomorphous. Below 86% r.h. the diffraction
quality deteriorated and the process was not reversible. This is
reminiscent of the complex dehydration behaviour observed
in HIV-1 reverse transcriptase crystals (Esnouf et al., 1998).
WbdD556 crystals often cracked during dehydration with the
FMS, degrading the diffraction quality. Covering the crystal in
perfluoropolyether oil, setting the r.h. to 92% and allowing the
dehydration to proceed overnight proved to be a reproducible
procedure.
From a practical perspective, however, this procedure was
not suited for the production of multiple crystals. We therefore
tested a commercially available dehydration kit (JBS Crystal
Dehydration and Salvage Kit), in which the r.h. is controlled
by a salt solution inside a cap which covers a mounted crystal.
This was unsuccessful either because the salt often crystallized
or because mechanical errors in placing the cap destroyed the
crystal. A different approach was devised that involved filling
the reservoirs of a 96-well crystallization plate (MRC plate)
with different saturated salt solutions (e.g. potassium nitrate,
ammonium sulfate, sodium chloride and magnesium chloride).
Using a cryoloop (MiTeGen), crystals were then placed into
0.5 ml perfluoropolyether oil drops (one crystal per drop) in
each well (Fig. 7). A cat whisker was used to push the crystal
out of the cryoloop into the oil drop if required. The plate
was then sealed and incubated for one week. Crystals were
harvested from the oil drop and cryocooled in liquid nitrogen
prior to the diffraction experiment. With WbdD, dehydration
with ammonium sulfate (r.h. 81%) reproducibly yielded
crystals that diffracted to better than 2.5 A˚ resolution. The
best diffracting crystals (which also belonged to space group
I23) had a unit-cell parameter of 158 A˚, which is again
considerably shorter than the 167 A˚ unit-cell parameter of
the native crystal that was used to solve the initial structure
(Table 2). The resulting high-resolution structure, complexes,
mutants and biological implications will be described else-
where.
4. Discussion
4.1. Effect of dehydration on the structure
After the structure of WbdD556 had been solved as
described above, the model was used to solve the structure of
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Figure 7
Schematic of our novel crystal-dehydration workflow. (a) A 96-well plate
was filled with different saturated salt solutions. (b) The crystal (red) was
harvested from its mother liquor and placed in a drop of perfluoro-
polyether oil (PFO-X175/08; Hampton Research) on the sitting-drop
shelf. The plate was then sealed and the setup was kept at room
temperature for a week before the crystals were harvested and flash-
cooled using liquid nitrogen prior to data collection.
Figure 8
(a) Rigid bodies (yellow and blue ribbons) in WbdD556 identified by
the RAPIDO webserver (Mosca & Schneider, 2008). Hinge regions are
shown as red ribbons and the cofactors ATP and SAM as spheres. (b)
Superposition of the 3.0 A˚ resolution (red) and 4.2 A˚ resolution (green)
WbdD structures (Table 2) showing the twisting motion that occurs
during crystal dehydration and pivots around the ATP-binding cleft. The
superposition is based on the rigid body that comprises the methyl-
transferase and the N-lobe of the kinase domain [coloured yellow in (a)].
the 4.2 A˚ low-resolution data set (Table 2) in order to inves-
tigate the structural changes that occurred during dehydra-
tion. The RAPIDO webserver was employed to align the two
structures (Mosca & Schneider, 2008; Mosca et al., 2008). The
algorithm detected two rigid bodies in WbdD. The first one
comprises residues 7–194, 203–230, 239–259, 264–314, 340–351
and 368–376 and represents the MTase domain together with
the N-lobe of the kinase domain (Fig. 8). The second rigid
body contains the C-lobe of the kinase domain (residues 315–
339, 352–367, 383–398 and 418–449). Superposing both struc-
tures based on the first rigid body revealed a twisting motion
with a hinge between the N- and C-lobes of the kinase domain
(ATP-binding cleft). In the highest resolution (better than
2.5 A˚) WbdD structures the ATP added to the crystallization
conditions was disordered. In these structures, the twisting
motion displaces the nucleotide from the binding pocket by
inserting protein residues into the binding cleft. There is a 20
movement of the C-terminal helix that forms the three-helix
bundle in the trimer. In the high-resolution structure this helix
is in much closer contact with the kinase domain (Fig. 8). In
retrospect, the rigid-body motion within the kinase domain
probably explains why molecular replacement based on a
single kinase domain failed. The structural changes are
striking when viewed in the crystal-packing environment
(Fig. 9). Four WbdD trimers organize themselves into a
pyramid-shaped arrangement that is centred on each corner of
a unit cell. During dehydration, this assembly is dramatically
compressed as the three arms of the trimers bind to each
other. This may explain why dehydration is so reproducible in
yielding good-quality crystals (Fig. 9).
We analyzed the two crystal-packing arrangements (dehy-
drated and non-dehydrated) using the PISA server (Krissinel
& Henrick, 2007). In the non-dehydrated form each WbdD556
monomer with a surface area of 21 000 A˚2 contributes to
three protein–protein interfaces. Each of these has a relatively
small interface area of 200 A˚2 formed by 6–8 amino-acid
residues. After dehydration, each WbdD556 monomer is
involved in five protein–protein interfaces; four of these have
interface areas between 400 and 700 A˚2 and involve up to 26
amino-acid residues at each interface. In the dehydrated state,
the interactions between WbdD556 monomers are so exten-
sive that PISA classifies both the whole pyramid-shaped
assembly (Fig. 9) and the trimer as being stable in solution. In
contrast, PISA did not define any of the interfaces in the ‘non-
dehydrated’ packing as being stable in
solution. This included the trimer, which
can be identified in solution by gel
filtration (data not shown).
Each of the WbdD556 structures
contains an 20-residue -helix
remaining from the C-terminal coiled-
coil domain (Fig. 1a). In the lower-
resolution structures we could model 5–
6 additional residues of the helix, but
the remaining80 residues were always
disordered. For four WbdD556 trimers
in one pyramid (Fig. 9), almost 1000
amino acids would have to fit into the
central cavity. A simple volume calcu-
lation revealed that the void is indeed
large enough to accommodate the
missing residues unless the remaining
residues formed a single helix. The
volume of the cavity shrinks during
dehydration, perhaps explaining why in
contrast to the rest of the structure the
helical bundle becomes more disor-
dered as the crystals are dehydrated.
The void is too small for constructs that
have a longer C-terminal bundle than
WbdD556 (Fig. 9).
More than ten years ago, at the outset
of structural genomics (SG) programs,
our laboratory solved the structure of
UDP-galactopyranose mutase (Sanders
et al., 2001). This project represented
a challenge owing to varying crystal
quality and non-isomorphism between
phased and unphased diffraction data
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Figure 9
Effect of dehydration on the trimeric WbdD structure and the crystal packing. The top row shows
the packing of the non-dehydrated crystal and the bottom row that of the dehydrated crystal. One
of the four WbdD556 trimers (surface representation) which are centred around each unit-cell
corner is shown in blue with a superimposed cartoon representation of the protein (white). In the
figure at the top right, the pyramid-shaped assembly shown on the left is cut open to reveal the size
of the internal hollow space.
sets. Despite the transformation in infrastructures (e.g.
beamlines) and software packages in the intervening years,
very similar problems were encountered with WbdD. One key
element in the process of solving the structure of WbdD was
the discovery of a plausible three-helix bundle in one low-
resolution electron-density map (Fig. 3a). The quantity of the
structural data in the PDB made this possible. Density-
modification software such as DMMULTI (Winn et al., 2011)
and PARROT (Cowtan, 2010) was essential in solving the
structure of WbdD. In a counter-intuitive outcome, dramati-
cally improved electron density was achieved by cross-crystal
averaging with the non-isomorphous low-resolution (but not
the high-resolution) data set (4.2 A˚ resolution; Table 2;
Fig. 3c). Use of electron density as a molecular-replacement
model with, for example, PHASER (McCoy et al., 2007) is now
much more automated and this was also critical to our success.
Although multiple cases are known in which crystals were
successfully dehydrated to improve their diffraction properties
(see, for example, Esnouf et al., 1998; Kiefersauer et al., 2000;
Chotiyarnwong et al., 2007), it is still a technique that is rarely
reported. This perhaps reflects frequent failure or technical
difficulties. WbdD may be a special case because the high
symmetry (I23) of the crystal lattice leads to isotropic changes
in the crystal and the novel packing arrangement was parti-
cularly favourable (Fig. 9). The effect of dehydration on
WbdD (an improvement in diffraction resolution from 8 to
2.2 A˚) is very pronounced when compared with other exam-
ples (Heras & Martin, 2005). However, a facile and easily
implementable protocol may extend the utility of dehydration.
The procedure described here combines several previously
published ideas (Kiefersauer et al., 2000; Heras & Martin,
2005) into an easy-to-use, low-cost and convenient workflow.
It is not anticipated that this will necessarily lead to more
success than other approaches, but it is straightforward and
amenable to high throughput. With robotic mounting and
testing of samples, the technique may be appropriate for
routine application for poorly diffracting high-solvent crystals.
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